rs61750615

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. BS1BP5PP4

This summary comes from the ClinGen Evidence Repository: NM_000552.5(VWF):c.6187C>T is a missense variant that replaces proline with serine at position 2063. The Grpmax filtering allele frequency in gnomAD v4.1 is 0.04661 (based on 4353/91066 alleles in the South Asian population, with 145 homozygotes), which is higher than the ClinGen VWD VCEP BS1 threshold of >0.01 (BS1). At least 1 proband harboring the variant in the homozygous state exhibits a history of severe bleeding and a quantitative defect in VWF, consistent with VWD Type 3 (PMID:23354996), however, it is not yet clear whether this phenotype is sufficiently specific to meet PP4. While this variant is also reported to be present in the homozygous state in multiple other affected probands (PMID:23354996), PS4 cannot be considered because BS1 is met. The recombinant p.Pro2063Ser variant in COS-7 cells matches properties of the wild-type recombinant protein, including normal expression, secretion, and multimer formation, inconsistent with a quantitative defect relevant to VWD Type 3 (PMID:19566550). BS3_Supporting is not met because this criterion is considered not applicable to this gene-disease relationship. This variant has been observed in affected cases with an alternate molecular basis for disease, including in VWD Type 3 in cis with either the NM_000552.5(VWF):c.970C>T (p.Arg324Ter) variant (PMID:33550700) or the NM_000552.5(VWF):c.5200C>T (p.Gln1734Ter) variant (PMID:23702511). Both comparison variants have been classified as Pathogenic by the ClinGen VWD VCEP. Three other reported cases with diverse VWD diagnoses harbor this variant as well as a second variant in VWF (PMID:19404524, PMID:21534937, PMID:16985174), however, the comparison variants have not yet been classified by the ClinGen VWD VCEP. In summary, this variant meets the criteria to be classified as Likely Benign for hereditary von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BS1, BP5, PP4. (VCEP Rule specifications for von Willebrand disease type 2A, 2B and 2M v1.0.0; date of approval 08/13/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA202650/MONDO:0019565/090

Frequency

Genomes: 𝑓 0.0075 ( 16 hom., cov: 31)
Exomes 𝑓: 0.010 ( 192 hom. )

Consequence

VWF
NM_000552.5 missense

Scores

4
10
4

Clinical Significance

Likely benign reviewed by expert panel U:1B:13O:1

Conservation

PhyloP100: 8.27

Publications

35 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP4
For more information check the summary or visit ClinGen Evidence Repository.
BP5
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.6187C>T p.Pro2063Ser missense_variant Exon 36 of 52 ENST00000261405.10 NP_000543.3 P04275-1
VWFXM_047429501.1 linkc.6187C>T p.Pro2063Ser missense_variant Exon 36 of 52 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.6187C>T p.Pro2063Ser missense_variant Exon 36 of 52 1 NM_000552.5 ENSP00000261405.5 P04275-1
VWFENST00000538635.5 linkn.421-550C>T intron_variant Intron 5 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.00748
AC:
1139
AN:
152172
Hom.:
16
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0126
Gnomad ASJ
AF:
0.0280
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0425
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00801
Gnomad OTH
AF:
0.00911
GnomAD2 exomes
AF:
0.0126
AC:
3178
AN:
251442
AF XY:
0.0149
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.0103
Gnomad ASJ exome
AF:
0.0246
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00129
Gnomad NFE exome
AF:
0.00825
Gnomad OTH exome
AF:
0.0165
GnomAD4 exome
AF:
0.0103
AC:
15042
AN:
1461852
Hom.:
192
Cov.:
32
AF XY:
0.0118
AC XY:
8580
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.00116
AC:
39
AN:
33480
American (AMR)
AF:
0.0111
AC:
495
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0243
AC:
635
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0481
AC:
4148
AN:
86250
European-Finnish (FIN)
AF:
0.00125
AC:
67
AN:
53420
Middle Eastern (MID)
AF:
0.0260
AC:
150
AN:
5768
European-Non Finnish (NFE)
AF:
0.00792
AC:
8806
AN:
1111984
Other (OTH)
AF:
0.0116
AC:
701
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
915
1830
2746
3661
4576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00747
AC:
1137
AN:
152290
Hom.:
16
Cov.:
31
AF XY:
0.00777
AC XY:
579
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41566
American (AMR)
AF:
0.0125
AC:
192
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0280
AC:
97
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0426
AC:
205
AN:
4816
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00801
AC:
545
AN:
68016
Other (OTH)
AF:
0.00854
AC:
18
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00871
Hom.:
29
Bravo
AF:
0.00741
TwinsUK
AF:
0.0102
AC:
38
ALSPAC
AF:
0.00856
AC:
33
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0107
AC:
92
ExAC
AF:
0.0127
AC:
1545
Asia WGS
AF:
0.0120
AC:
41
AN:
3478
EpiCase
AF:
0.0113
EpiControl
AF:
0.0111

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:13Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:4Other:1
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

VWF: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 24, 2022
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Academic Unit of Haematology, University of Sheffield
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Hereditary von Willebrand disease Uncertain:1Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2019
Genetics and Molecular Pathology, SA Pathology
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 13, 2024
ClinGen von Willebrand Disease Variant Curation Expert Panel, ClinGen
Significance:Likely benign
Review Status:reviewed by expert panel
Collection Method:curation

NM_000552.5(VWF):c.6187C>T is a missense variant that replaces proline with serine at position 2063. The Grpmax filtering allele frequency in gnomAD v4.1 is 0.04661 (based on 4353/91066 alleles in the South Asian population, with 145 homozygotes), which is higher than the ClinGen VWD VCEP BS1 threshold of >0.01 (BS1). At least 1 proband harboring the variant in the homozygous state exhibits a history of severe bleeding and a quantitative defect in VWF, consistent with VWD Type 3 (PMID: 23354996), however, it is not yet clear whether this phenotype is sufficiently specific to meet PP4. While this variant is also reported to be present in the homozygous state in multiple other affected probands (PMID: 23354996), PS4 cannot be considered because BS1 is met. The recombinant p.Pro2063Ser variant in COS-7 cells matches properties of the wild-type recombinant protein, including normal expression, secretion, and multimer formation, inconsistent with a quantitative defect relevant to VWD Type 3 (PMID: 19566550). BS3_Supporting is not met because this criterion is considered not applicable to this gene-disease relationship. This variant has been observed in affected cases with an alternate molecular basis for disease, including in VWD Type 3 in cis with either the NM_000552.5(VWF):c.970C>T (p.Arg324Ter) variant (PMID: 33550700) or the NM_000552.5(VWF):c.5200C>T (p.Gln1734Ter) variant (PMID: 23702511). Both comparison variants have been classified as Pathogenic by the ClinGen VWD VCEP. Three other reported cases with diverse VWD diagnoses harbor this variant as well as a second variant in VWF (PMID: 19404524, PMID: 21534937, PMID: 16985174), however, the comparison variants have not yet been classified by the ClinGen VWD VCEP. In summary, this variant meets the criteria to be classified as Likely Benign for hereditary von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BS1, BP5, PP4. (VCEP Rule specifications for von Willebrand disease type 2A, 2B and 2M v1.0.0; date of approval 08/13/2024) -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 17, 2014
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

von Willebrand disease type 1 Benign:2
Dec 10, 2020
Laboratory of Hematology, Radboud University Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.27
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.0080
T
MetaSVM
Uncertain
-0.18
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
8.3
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-3.5
D
REVEL
Uncertain
0.44
Sift
Uncertain
0.027
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.30
MPC
0.92
ClinPred
0.0098
T
GERP RS
4.9
Varity_R
0.27
gMVP
0.85
Mutation Taster
=28/72
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61750615; hg19: chr12-6103650; COSMIC: COSV108805184; API